| Mitomycin studied in …STUDIED_INderived129 of 129show fewer |
|---|
| → studied in | NCT06770582Phase 2 · recruiting Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm,Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06919965Phase 3 · recruiting A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer · 129 trials list this drug (37 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06211764Phase 3 · active not recruiting A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) · 129 trials list this drug (37 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07271355Phase 3 · recruiting Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial · 129 trials list this drug (37 active) | — | — | Appendix Carcinoma,Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06227065Phase 2 · not yet recruiting Precise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived Organoids · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07487168Phase 1 · recruiting Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors · 129 trials list this drug (37 active) | — | — | Peritoneal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821177early Phase 1 · active not recruiting Bladder Preservation or Cystectomy for MIBC · 129 trials list this drug (37 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm,Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04166318Phase 2 · active not recruiting Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study · 129 trials list this drug (37 active) | — | — | Anal Basaloid Carcinoma,Anal Canal Squamous Cell Carcinoma,Anal Margin Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07566156Phase 3 · recruiting Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309) · 129 trials list this drug (37 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04107077Phase 2 · recruiting Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer · 129 trials list this drug (37 active) | — | — | Malignant Gastric Neoplasm,Peritoneal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07189793Phase 2 · not yet recruiting Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study · 129 trials list this drug (37 active) | — | — | Transitional Cell Carcinoma,Bladder Neoplasm,Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03775265Phase 3 · active not recruiting Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer · 129 trials list this drug (37 active) | — | — | Bladder Urothelial Carcinoma,Malignant Bladder Neoplasm,Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04329494Phase 1 · recruiting PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer · 129 trials list this drug (37 active) | — | — | Malignant Solid Neoplasm,Appendix Carcinoma,Gastric Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04847063Phase 1 · recruiting Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies · 129 trials list this drug (37 active) | — | — | Malignant Digestive System Neoplasm,Peritoneal Mesothelial Neoplasm,Malignant Appendix Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07097142Phase 3 · recruiting Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm,Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07424287Phase 3 · recruiting A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC · 129 trials list this drug (37 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05024734Phase 2 · active not recruiting Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07692152Phase 3 · recruiting Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell Carcinoma · 129 trials list this drug (37 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07671534Phase 2 · recruiting Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors · 129 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04929028Phase 2 · active not recruiting Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer · 129 trials list this drug (37 active) | — | — | Anal Squamous Cell Carcinoma,AIDS-Related Anal Carcinoma,Anal Margin Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07646145Phase 2 · recruiting Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder Cancer · 129 trials list this drug (37 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06783491Phase 3 · recruiting Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Colon Cancer · 129 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06388720Phase 2 · recruiting The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02106572Phase 3 · terminated Therapeutic Instillation of Mistletoe · 129 trials list this drug (37 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02710734Phase 2 · completed Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) · 129 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04216290Phase 2 · active not recruiting A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial · 129 trials list this drug (37 active) | — | — | Bladder Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05243550Phase 3 · active not recruiting A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer · 129 trials list this drug (37 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04241185Phase 3 · active not recruiting Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) · 129 trials list this drug (37 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06704191Phase 1/Phase 2 · recruiting In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm,Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05672108Phase 2 · recruiting Phase II Trial of Lung Chemoemobolization · 129 trials list this drug (37 active) | — | — | Mediastinal Neoplasm,Pleural Neoplasm,Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03348969Phase 4 · completed Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06513065Phase 3 · recruiting Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP) · 129 trials list this drug (37 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01858025early Phase 1 · completed Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma · 129 trials list this drug (37 active) | — | — | Anal Canal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05838391NA · recruiting Adaptive Radiation in Anal Cancer · 129 trials list this drug (37 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05902533Phase 2/Phase 3 · active not recruiting REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation · 129 trials list this drug (37 active) | — | — | Malignant Anal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02369458Phase 2 · completed Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies · 129 trials list this drug (37 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06781879Phase 4 · recruiting Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer · 129 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04200417Phase 1 · completed Chemoembolization for Lung Tumors · 129 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03092518Phase 2 · completed Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology · 129 trials list this drug (37 active) | — | — | Malignant Gastric Neoplasm,Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06696794Phase 3 · recruiting Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients · 129 trials list this drug (37 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02299999Phase 2 · active not recruiting SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer · 129 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01167725Phase 3 · terminated Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer · 129 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03658304Phase 2 · completed Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma · 129 trials list this drug (37 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02040142Phase 2 · completed HIPEC for Peritoneal Carcinomatosis · 129 trials list this drug (37 active) | — | — | Peritoneal Mesothelial Neoplasm,Malignant Appendix Neoplasm,Malignant Gastric Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00981656Phase 2 · completed Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02891447Phase 2 · completed Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer · 129 trials list this drug (37 active) | — | — | Gastric Adenocarcinoma,Gastroesophageal Junction Adenocarcinoma,Peritoneal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05136898Phase 3 · completed Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC) · 129 trials list this drug (37 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06462001Phase 3 · active not recruiting BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer · 129 trials list this drug (37 active) | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04688931Phase 3 · terminated A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer · 129 trials list this drug (37 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01004978Phase 3 · completed Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery · 129 trials list this drug (37 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914820NA · unknown Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Colorectal Carcinoma. CHECK Study. · 129 trials list this drug (37 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02614534Phase 3 · unknown Clinical Trial to Evaluate Safety and Efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) With Mitomycin C Used During Surgery for Treatment of Locally Advanced Colorectal Carcinoma · 129 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05979909Phase 1 · not yet recruiting Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma · 129 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003907Phase 2 · completed Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver · 129 trials list this drug (37 active) | — | — | Malignant Neoplasm,Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02948543Phase 3 · unknown Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03073694Phase 2 · unknown Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis · 129 trials list this drug (37 active) | — | — | Malignant Appendix Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05688488Phase 1/Phase 2 · recruiting Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords · 129 trials list this drug (37 active) | — | — | Laryngeal Squamous Papilloma,Glottis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02695771Phase 3 · completed The Bladder Instillation Comparison Study · 129 trials list this drug (37 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03330028Phase 1 · completed Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology · 129 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03617913Phase 2 · completed Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm,Malignant Ureter Neoplasm,Malignant Urethral Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03558503Phase 2 · completed A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer · 129 trials list this drug (37 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03604653completed Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers · 129 trials list this drug (37 active) | — | — | Malignant Appendix Neoplasm,Malignant Gastric Neoplasm,Primary Peritoneal Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02316171Phase 1 · completed CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON) · 129 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04845490Phase 2 · unknown Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy · 129 trials list this drug (37 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01324141Phase 1 · terminated Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer · 129 trials list this drug (37 active) | — | — | Malignant Anal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00318643Phase 1/Phase 2 · completed Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02092298Phase 2 · completed Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer · 129 trials list this drug (37 active) | — | — | Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005944Phase 2 · terminated Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer · 129 trials list this drug (37 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023868Phase 3 · terminated Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) · 129 trials list this drug (37 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02070120Phase 2 · unknown Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01621217Phase 1 · completed Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0 · 129 trials list this drug (37 active) | — | — | Anal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01671488Phase 1/Phase 2 · terminated A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer · 129 trials list this drug (37 active) | — | — | Malignant Anal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02982395Phase 3 · terminated Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC · 129 trials list this drug (37 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00423293Phase 2 · completed Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer · 129 trials list this drug (37 active) | — | — | Malignant Anal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03790384Phase 4 · unknown Sequential Combination Therapy in Bladder Cancer · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00276744Phase 2 · terminated Individualized Drug Treatment for Treating Patients With Pancreatic Cancer · 129 trials list this drug (37 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00386399Phase 2 · withdrawn Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene · 129 trials list this drug (37 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01580410Phase 2 · completed Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix · 129 trials list this drug (37 active) | — | — | Appendix Neoplasm,Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003003Phase 1 · completed Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia · 129 trials list this drug (37 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03381352Phase 2 · unknown Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer · 129 trials list this drug (37 active) | — | — | Malignant Anal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01011010Phase 1 · completed Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery · 129 trials list this drug (37 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00201747Phase 2 · completed Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer · 129 trials list this drug (37 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00265863Phase 2 · terminated Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites · 129 trials list this drug (37 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01200992Phase 3 · terminated Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer · 129 trials list this drug (37 active) | — | — | Carcinoma In Situ,Transitional Cell Carcinoma,Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02369939Phase 3 · unknown Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy · 129 trials list this drug (37 active) | — | — | Anal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02199327Phase 4 · completed Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia · 129 trials list this drug (37 active) | — | — | Corneal Squamous Intraepithelial Neoplasia,Conjunctival Squamous Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01171482Phase 2 · terminated Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma · 129 trials list this drug (37 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003596Phase 3 · completed Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer · 129 trials list this drug (37 active) | — | — | Malignant Anal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01017640Phase 1 · completed Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors · 129 trials list this drug (37 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01843452Phase 2 · terminated Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal · 129 trials list this drug (37 active) | — | — | Anal Canal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01953406Phase 2 · withdrawn The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma · 129 trials list this drug (37 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01296763Phase 1 · completed Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer · 129 trials list this drug (37 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02638857Phase 1/Phase 2 · unknown Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma · 129 trials list this drug (37 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00271011Phase 2 · terminated A Study of Mitomycin C, Irinotecan, and Cetuximab · 129 trials list this drug (37 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02311101Phase 1 · completed Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer · 129 trials list this drug (37 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00974818Phase 3 · terminated Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00734994early Phase 1 · completed Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer · 129 trials list this drug (37 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00024271Phase 2 · unknown Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer · 129 trials list this drug (37 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003893Phase 3 · completed Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer · 129 trials list this drug (37 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002490Phase 3 · completed Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003240Phase 3 · unknown Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer · 129 trials list this drug (37 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005825Phase 2 · unknown Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer · 129 trials list this drug (37 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00024349Phase 3 · completed Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003159Phase 3 · completed Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer · 129 trials list this drug (37 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005870Phase 3 · unknown Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas · 129 trials list this drug (37 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004887Phase 3 · unknown Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery · 129 trials list this drug (37 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025090Phase 3 · completed Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer · 129 trials list this drug (37 active) | — | — | Malignant Anal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01094964Phase 3 · unknown Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004209Phase 3 · unknown Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer · 129 trials list this drug (37 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030459Phase 2 · unknown Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma · 129 trials list this drug (37 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075699Phase 3 · completed Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma · 129 trials list this drug (37 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002507Phase 3 · completed Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer · 129 trials list this drug (37 active) | — | — | Malignant Head and Neck Neoplasm,Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002993Phase 2 · terminated Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus · 129 trials list this drug (37 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00033644Phase 2 · terminated Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus · 129 trials list this drug (37 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01042041Phase 1 · completed Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer · 129 trials list this drug (37 active) | — | — | Hepatocellular Carcinoma,Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00289445Phase 1/Phase 2 · completed Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) · 129 trials list this drug (37 active) | — | — | Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003018Phase 2 · completed S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer · 129 trials list this drug (37 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023842Phase 2 · completed BCG With or Without Mitomycin in Treating Patients With Bladder Cancer · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042887Phase 3 · terminated Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer · 129 trials list this drug (37 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068744Phase 2/Phase 3 · terminated Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer · 129 trials list this drug (37 active) | — | — | Malignant Anal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003710Phase 1 · completed Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors · 129 trials list this drug (37 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003209Phase 3 · completed Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer · 129 trials list this drug (37 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01327521Phase 3 · withdrawn Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma · 129 trials list this drug (37 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00967291Phase 2 · terminated Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer · 129 trials list this drug (37 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01149174Phase 3 · completed Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer · 129 trials list this drug (37 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00652860Phase 2 · completed Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery · 129 trials list this drug (37 active) | — | — | Malignant Neoplasm,Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006112Phase 2 · unknown Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer · 129 trials list this drug (37 active) | — | — | Appendix Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00148395Phase 3 · completed Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy. · 129 trials list this drug (37 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00192049Phase 2 · completed A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer · 129 trials list this drug (37 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |